Comparative analysis of roxadustat efficacy between maintenance hemodialysis and peritoneal dialysis patients

Liling Zhang, Yan Huang, Defeng Yin, Tingting Zhu, Qi Liu, Ying Li, Linwang GanClinical 2023 · DOI

Abstract

Roxadustat can effectively increase the hemoglobin level of maintenance dialysis patients, even in those with low erythropoietin response or erythropoietin resistance, and, more importantly, its efficacy in PD patients was more significant.
BibTeX
@inproceedings{zhang2023comparative,
  author = {Liling Zhang and Yan Huang and Defeng Yin and Tingting Zhu and Qi Liu and Ying Li and Linwang Gan},
  title = {{Comparative analysis of roxadustat efficacy between maintenance hemodialysis and peritoneal dialysis patients}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.5414/cn111144},
}

Loading related content...

Figure